Baby Safety / Compounds / Metoclopramide

Is Metoclopramide safe for babies and kids?

Context-dependent for kids

(Babies-specific data is limited; this page draws from human pregnant context.) Pregnancy alters the metabolism and distribution of Metoclopramide, potentially increasing fetal exposure. The developing embryo/fetus is vulnerable during organogenesis (weeks 3-8) and neurological development. Placental transfer should be assumed.

What is metoclopramide?

The IUPAC name is 4-amino-5-chloro-N-[2-(diethylamino)ethyl]-2-methoxybenzamide.

Also known as: Methochlopramide, Metochlopramide, Reliveran, Metaclopramide.

IUPAC name
4-amino-5-chloro-N-[2-(diethylamino)ethyl]-2-methoxybenzamide
CAS number
364-62-5
Molecular formula
C14H22ClN3O2
Molecular weight
299.8 g/mol
SMILES
CCN(CC)CCNC(=O)c1cc(Cl)c(N)cc1OC
PubChem CID
4168

Risk for babies

Context-dependent

Pregnancy alters the metabolism and distribution of Metoclopramide, potentially increasing fetal exposure. The developing embryo/fetus is vulnerable during organogenesis (weeks 3-8) and neurological development. Placental transfer should be assumed.

No specific reproductive toxicity data identified, but pregnancy-specific safety data is limited for most chemicals. Precautionary minimization of exposure is recommended.

What to do: Minimize exposure during pregnancy and lactation. Consult healthcare provider regarding specific risks. Consider alternative products with lower hazard profiles.

Risk for pregnant and nursing people

Context-dependent

Pregnancy alters the metabolism and distribution of Metoclopramide, potentially increasing fetal exposure. The developing embryo/fetus is vulnerable during organogenesis (weeks 3-8) and neurological development. Placental transfer should be assumed.

No specific reproductive toxicity data identified, but pregnancy-specific safety data is limited for most chemicals. Precautionary minimization of exposure is recommended.

What to do: Minimize exposure during pregnancy and lactation. Consult healthcare provider regarding specific risks. Consider alternative products with lower hazard profiles.

Regulatory consensus

2 regulatory and scientific bodies have classified Metoclopramide. The classifications differ — that's the data.

AgencyYearClassificationNotes
FDA2009Approved human drug (NDA 017854); black box warning for tardive dyskinesia
EMA2013Approved; restricted to short-term use ≤5 days

Regulators apply different standards of evidence — animal-data weighting, exposure-pattern assumptions, epidemiological power thresholds — which is why two scientific bodies can review the same data and reach different conclusions. The disagreement is the data.

Where kids encounter metoclopramide

  • Pharmaceutical
  • Wastewater

Safer alternatives

Lower-risk approaches that achieve a similar outcome to Metoclopramide:

  • Ondansetron (fewer extrapyramidal effects)
    Trade-offs: Removes 95-99% of dissolved contaminants including metals, PFAS, nitrates; wastes 2-4 gallons per gallon produced (improving with newer systems); removes beneficial minerals; $0.05-0.25/gallon; requires pre-treatment for longevity.
    Relative cost: 1.2-2×
  • Maropitant / Cerenia (veterinary-specific)
    Trade-offs: Removes 95-99% of dissolved contaminants including metals, PFAS, nitrates; wastes 2-4 gallons per gallon produced (improving with newer systems); removes beneficial minerals; $0.05-0.25/gallon; requires pre-treatment for longevity.
    Relative cost: 1.2-2×

Frequently asked questions

No FAQ entries generated.

See Metoclopramide in the baby app

Look up products containing metoclopramide, compare to alternatives, and explore the full data record.

Open in baby View raw API data

Sources (1)
  1. —

Reference data, not professional advice. Aggregates publicly available regulatory and scientific data; not a substitute for veterinary, medical, legal, or regulatory advice. Why we built ALETHEIA →